12 transactions in one company, from February 6, 2026 to September 15, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | RXRX | 12 | — | $68K |
12 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Sep 15 | F | 5,396 | $3.41 | $18K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Aug 17 | F | 25,018 | $3.16 | $79K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Jun 15 | F | 5,396 | $3.15 | $17K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | May 15 | F | 25,018 | $3.04 | $76K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Apr 6 | F | 48,028 | $3.11 | $149K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Mar 17 | SPLAN | 7,956 | $3.39 | $27K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Mar 16 | FPLAN | 7,075 | $3.42 | $24K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Feb 18 | SPLAN | 13,426 | $3.08 | $41K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Feb 17 | FPLAN | 11,908 | $3.49 | $42K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Feb 6 | F | 11,400 | $3.98 | $45K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Feb 6 | A | 24,254 | $0.00 | — |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Ben R. TaylorCFO | Feb 6 | A | 446,279 | $0.00 | — |